ID   NONO_RAT                Reviewed;         476 AA.
AC   Q5FVM4;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 3.
DT   29-MAY-2024, entry version 141.
DE   RecName: Full=Non-POU domain-containing octamer-binding protein;
DE            Short=NonO protein;
GN   Name=Nono;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   FUNCTION IN CIRCADIAN RHYTHMS, AND INTERACTION WITH PER1.
RX   PubMed=15860628; DOI=10.1126/science.1107373;
RA   Brown S.A., Ripperger J., Kadener S., Fleury-Olela F., Vilbois F.,
RA   Rosbash M., Schibler U.;
RT   "PERIOD1-associated proteins modulate the negative limb of the mammalian
RT   circadian oscillator.";
RL   Science 308:693-696(2005).
CC   -!- FUNCTION: DNA- and RNA binding protein, involved in several nuclear
CC       processes (By similarity). Binds the conventional octamer sequence in
CC       double-stranded DNA (By similarity). Also binds single-stranded DNA and
CC       RNA at a site independent of the duplex site (By similarity). Involved
CC       in pre-mRNA splicing, probably as a heterodimer with SFPQ (By
CC       similarity). Interacts with U5 snRNA, probably by binding to a purine-
CC       rich sequence located on the 3' side of U5 snRNA stem 1b (By
CC       similarity). Together with PSPC1, required for the formation of nuclear
CC       paraspeckles (By similarity). The SFPQ-NONO heteromer associated with
CC       MATR3 may play a role in nuclear retention of defective RNAs (By
CC       similarity). The SFPQ-NONO heteromer may be involved in DNA unwinding
CC       by modulating the function of topoisomerase I/TOP1 (By similarity). The
CC       SFPQ-NONO heteromer may be involved in DNA non-homologous end joining
CC       (NHEJ) required for double-strand break repair and V(D)J recombination
CC       and may stabilize paired DNA ends (By similarity). In vitro, the
CC       complex strongly stimulates DNA end joining, binds directly to the DNA
CC       substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to
CC       establish a functional preligation complex (By similarity). NONO is
CC       involved in transcriptional regulation (By similarity). The SFPQ-NONO-
CC       NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-
CC       dependent transcriptional activity (By similarity). NONO binds to an
CC       enhancer element in long terminal repeats of endogenous intracisternal
CC       A particles (IAPs) and activates transcription (By similarity).
CC       Regulates the circadian clock by repressing the transcriptional
CC       activator activity of the CLOCK-BMAL1 heterodimer (PubMed:15860628).
CC       Important for the functional organization of GABAergic synapses (By
CC       similarity). Plays a specific and important role in the regulation of
CC       synaptic RNAs and GPHN/gephyrin scaffold structure, through the
CC       regulation of GABRA2 transcript (By similarity). Plays a key role
CC       during neuronal differentiation by recruiting TET1 to genomic loci and
CC       thereby regulating 5-hydroxymethylcytosine levels (By similarity).
CC       Plays a role in the regulation of DNA virus-mediated innate immune
CC       response by assembling into the HDP-RNP complex, a complex that serves
CC       as a platform for IRF3 phosphorylation and subsequent innate immune
CC       response activation through the cGAS-STING pathway (By similarity).
CC       {ECO:0000250|UniProtKB:Q15233, ECO:0000250|UniProtKB:Q99K48,
CC       ECO:0000269|PubMed:15860628}.
CC   -!- SUBUNIT: Monomer and component of the SFPQ-NONO complex, which is
CC       probably a heterotetramer of two 52 kDa (NONO) and two 100 kDa (SFPQ)
CC       subunits. NONO is a component of spliceosome and U5.4/6 snRNP complexes
CC       (By similarity). Interacts with CPNE4 (via VWFA domain) (By
CC       similarity). Forms heterodimers with PSPC1; this involves formation of
CC       a coiled coil domain by helices from both proteins. Part of complex
CC       consisting of SFPQ, NONO and MATR3. Part of a complex consisting of
CC       SFPQ, NONO and NR5A1. Part of a complex consisting of SFPQ, NONO and
CC       TOP1. Interacts with SPI1 and SPIB. Interacts with RNF43 (By
CC       similarity). Interacts with PER1 and PER2 (PubMed:15860628). Part of
CC       the HDP-RNP complex composed of at least HEXIM1, PRKDC, XRCC5, XRCC6,
CC       paraspeckle proteins (SFPQ, NONO, PSPC1, RBM14, and MATR3) and NEAT1
CC       RNA. Interacts (via second RRM domain) with WASL; the interaction is
CC       direct. Component of a multiprotein complex with WASL and SFPQ (By
CC       similarity). Interacts with ERCC6 (By similarity). Interacts (via DNA-
CC       binding domain) with TET1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q15233, ECO:0000250|UniProtKB:Q99K48,
CC       ECO:0000269|PubMed:15860628}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q15233}. Nucleus,
CC       nucleolus {ECO:0000250|UniProtKB:Q15233}. Nucleus speckle
CC       {ECO:0000250|UniProtKB:Q15233}. Chromosome
CC       {ECO:0000250|UniProtKB:Q99K48}. Note=Detected in punctate subnuclear
CC       structures often located adjacent to splicing speckles, called
CC       paraspeckles. {ECO:0000250|UniProtKB:Q15233}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC089880; AAH89880.1; -; mRNA.
DR   RefSeq; NP_001012356.1; NM_001012356.1.
DR   AlphaFoldDB; Q5FVM4; -.
DR   BMRB; Q5FVM4; -.
DR   SMR; Q5FVM4; -.
DR   BioGRID; 261496; 3.
DR   CORUM; Q5FVM4; -.
DR   IntAct; Q5FVM4; 3.
DR   MINT; Q5FVM4; -.
DR   STRING; 10116.ENSRNOP00000004911; -.
DR   iPTMnet; Q5FVM4; -.
DR   PhosphoSitePlus; Q5FVM4; -.
DR   SwissPalm; Q5FVM4; -.
DR   jPOST; Q5FVM4; -.
DR   PaxDb; 10116-ENSRNOP00000004911; -.
DR   Ensembl; ENSRNOT00000004911.6; ENSRNOP00000004911.4; ENSRNOG00000003689.7.
DR   Ensembl; ENSRNOT00055051206; ENSRNOP00055042181; ENSRNOG00055029571.
DR   Ensembl; ENSRNOT00060046815; ENSRNOP00060038934; ENSRNOG00060027002.
DR   Ensembl; ENSRNOT00065029057; ENSRNOP00065023020; ENSRNOG00065017402.
DR   GeneID; 317259; -.
DR   KEGG; rno:317259; -.
DR   UCSC; RGD:1549738; rat.
DR   AGR; RGD:1549738; -.
DR   CTD; 4841; -.
DR   RGD; 1549738; Nono.
DR   eggNOG; KOG0115; Eukaryota.
DR   GeneTree; ENSGT00940000154442; -.
DR   HOGENOM; CLU_027185_2_0_1; -.
DR   InParanoid; Q5FVM4; -.
DR   OMA; PNRPGEQ; -.
DR   OrthoDB; 5403433at2759; -.
DR   PhylomeDB; Q5FVM4; -.
DR   TreeFam; TF315795; -.
DR   ChiTaRS; Nono; rat.
DR   PRO; PR:Q5FVM4; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000003689; Expressed in thymus and 20 other cell types or tissues.
DR   ExpressionAtlas; Q5FVM4; baseline and differential.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016363; C:nuclear matrix; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0042382; C:paraspeckles; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0106222; F:lncRNA binding; IDA:RGD.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0002218; P:activation of innate immune response; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IMP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:1903377; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IBA:GO_Central.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   CDD; cd12946; NOPS_p54nrb_PSF_PSPC1; 1.
DR   CDD; cd12588; RRM1_p54nrb; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   Gene3D; 6.10.250.1170; -; 1.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034552; p54nrb_RRM1.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR23189:SF15; NON-POU DOMAIN-CONTAINING OCTAMER-BINDING PROTEIN; 1.
DR   PANTHER; PTHR23189; RNA RECOGNITION MOTIF-CONTAINING; 1.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Biological rhythms; Chromosome; Coiled coil;
KW   DNA damage; DNA recombination; DNA repair; DNA-binding; Immunity;
KW   Innate immunity; Isopeptide bond; Methylation; mRNA processing;
KW   mRNA splicing; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; RNA-binding; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..476
FT                   /note="Non-POU domain-containing octamer-binding protein"
FT                   /id="PRO_0000081686"
FT   DOMAIN          80..147
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          154..235
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          1..56
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          60..379
FT                   /note="DBHS"
FT                   /evidence="ECO:0000250"
FT   REGION          448..476
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          274..378
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99K48"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   MOD_RES         6
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   MOD_RES         11
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   MOD_RES         152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   MOD_RES         203
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   MOD_RES         267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   MOD_RES         300
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99K48"
FT   MOD_RES         376
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99K48"
FT   MOD_RES         433
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   MOD_RES         445
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   MOD_RES         455
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   MOD_RES         461
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        5
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        65
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        101
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        104
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        131
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        195
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        203
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        248
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        254
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        376
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
FT   CROSSLNK        472
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15233"
SQ   SEQUENCE   476 AA;  54925 MW;  47521721B46E5597 CRC64;
     MQSNKTFNLE KQNHTPRKHH QHHHQQHHQQ QQQQQQQQQQ QPPPPIPANG QQASSQNEGL
     TIDLKNFRKP GEKTFTQRSR LFVGNLPPDI TEEEMRKLFE KYGKAGEVFI HKDKGFGFIR
     LETRTLAEIA KVELDNMPLR GKQLRVRFAC HSASLTVRNL PQYVSNELLE EAFSVFGQVE
     RAVVIVDDRG RPSGKGIVEF SGKPAARKAL DRCSEGSFLL TTFPRPVTVE PMDQLDDEEG
     LPEKLVIKNQ QFHKEREQPP RFAQPGSFEY EYAMRWKALI EMEKQQQDQV DRNIKEAREK
     LEMEMEAARH EHQVMLMRQD LMRRQEELRR MEELHNQEVQ KRKQLELRQE EERRRREEEM
     RRQQEEMMRR QQEGFKGTFP DAREQEIRMG QMAMGGAMGI NNRGAMPPAP VPPGTPAPPG
     PAAMMPDGTL GLTPPTTERF GQAATMEGIG AIGGTPPAFN RPAPGAEFAP NKRRRY
//
